|
|
| MRD / Regn No. |
: SG2429 |
Date |
: 16/07/2026 |
| Patient Name |
: Dinesh Doshi |
Age & Gender |
: 70 Yrs. / Male |
| Contact No. |
: 9831831931 |
UHID |
: |
| Ht / Wt / BMI |
: 160 / 83 / 32.42 |
BP S / BP D |
: 142 / 76 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (23/Sep/2012) | HYPERTENSION (23/Sep/2022) | GLAUCOMA (23/Sep/2022) | HYPOTHYROID (23/Sep/2022) | |
| Salient Investigations |
: |
HBA1C GLYCOSYLATED HEMOGLOBIN: 7.2 % |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ATORVASTATIN 20 MG TONACT 20 MG |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
2 |
THYROXINE 25 MCG THYRONORM 25 MCG Medicine For LOW THYROID |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
3 |
TABLET TELMISARTAN 40 MG + ATORVASTATIN 10 MG ARBITEL AV Medicine For PO |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
4 |
INJECTION DEGLUDEC (INJ U100) TRESIBA Medicine For DIABETES |
SQ |
0-0-12 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
5 |
INJECTION FAST ASPART (INJ U100) FIASP Medicine For T1DM, T2DM |
SQ |
0-10-0 |
BEFORE LUNCH
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
6 |
ANTIHYPERGLYCEMIC SITAGLIPTIN 100 MG + DAPAGLIFLOZIN 10 MG + METFORMIN 1000 MG LUPISIT DM 1000 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
7 |
METFORMIN SR 1000 MG GLYCOMET SR |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 16/Jan/2027 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,CREATININE |
| |
|
| |
|
 Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |